RayBiotech to Help Banner Sun Health Investigate Neurodegenerative Disease Biomarkers | GenomeWeb

NEW YORK (GenomeWeb News) – RayBiotech said late Thursday that it has executed a master services agreement with Banner Sun Health Research Institute for the analysis of biomarkers of neurodegenerative disorders.

Under the agreement, RayBiotech will provide services for the analysis of biomarkers with a particular focus on ailments such as Alzheimer's and Parkinson diseases. The company's platform can be used to evaluate both the identity and quantity of biomarkers in a comprehensive, high-throughput manner, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.